181 related articles for article (PubMed ID: 27055370)
1. High-Dose Chemotherapy in a Late Relapse, Platinum-Refractory Nonseminomatous Germ Cell Tumor.
Connell BJ; Patel MJ; Tretter CG
Clin Genitourin Cancer; 2016 Aug; 14(4):e441-3. PubMed ID: 27055370
[No Abstract] [Full Text] [Related]
2. Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group.
Kollmannsberger C; Rick O; Derigs HG; Schleucher N; Schöffski P; Beyer J; Schoch R; Sayer HG; Gerl A; Kuczyk M; Spott C; Kanz L; Bokemeyer C
J Clin Oncol; 2002 Apr; 20(8):2031-7. PubMed ID: 11956262
[TBL] [Abstract][Full Text] [Related]
3. Why doesn't high-dose chemotherapy improve survival, as was expected, in advanced or relapsed germ cell tumours?
Pizzocaro G; Guarneri A
Eur Urol; 2009 Jul; 56(1):46-7. PubMed ID: 19303203
[No Abstract] [Full Text] [Related]
4. Growth and chemotherapy of a human germ-cell tumour line (GCT 27).
Schlappack OK; Bush C; Delic JI; Steel GG
Strahlenther Onkol; 1989 Jul; 165(7):541. PubMed ID: 2473535
[No Abstract] [Full Text] [Related]
5. Phase II evaluation of iproplatin in refractory germ cell tumors: a Southeastern Cancer Study Group trial.
Drasga RE; Williams SD; Einhorn LH; Birch R
Cancer Treat Rep; 1987 Sep; 71(9):863-4. PubMed ID: 3040247
[No Abstract] [Full Text] [Related]
6. [Platinum antitumor complexes].
Bonetti A; Giuliani J; Muggia F
Recenti Prog Med; 2015 Dec; 106(12):618-28. PubMed ID: 26780071
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of everolimus in refractory testicular germ cell tumors.
Mego M; Svetlovska D; Miskovska V; Obertova J; Palacka P; Rajec J; Sycova-Mila Z; Chovanec M; Rejlekova K; Zuzák P; Ondrus D; Spanik S; Reckova M; Mardiak J
Urol Oncol; 2016 Mar; 34(3):122.e17-22. PubMed ID: 26612480
[TBL] [Abstract][Full Text] [Related]
8. Targeted treatment approaches in refractory germ cell tumors.
Galvez-Carvajal L; Sanchez-Muñoz A; Ribelles N; Saez M; Baena J; Ruiz S; Ithurbisquy C; Alba E
Crit Rev Oncol Hematol; 2019 Nov; 143():130-138. PubMed ID: 31634730
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin in non-seminomatous germ-cell tumors.
Fizazi K; Culine S; Chen I
Ann Oncol; 2004 Aug; 15(8):1295. PubMed ID: 15277272
[No Abstract] [Full Text] [Related]
10. Selected use of aggressive adjuvant chemotherapy in resected stage II nonseminomatous germ cell tumors of the testis.
Pizzocaro G
Prog Clin Biol Res; 1985; 203():585-90. PubMed ID: 2421344
[No Abstract] [Full Text] [Related]
11. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
Einhorn LH; Williams SD; Chamness A; Brames MJ; Perkins SM; Abonour R
N Engl J Med; 2007 Jul; 357(4):340-8. PubMed ID: 17652649
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of "late" in the management of late relapse after treatment for a germ cell tumor.
Toner GC
J Clin Oncol; 2008 Dec; 26(34):5502-3. PubMed ID: 18936469
[No Abstract] [Full Text] [Related]
13. Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation.
Zschäbitz S; Lasitschka F; Hadaschik B; Hofheinz RD; Jentsch-Ullrich K; Grüner M; Jäger D; Grüllich C
Eur J Cancer; 2017 May; 76():1-7. PubMed ID: 28262583
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of 1,2-diaminocyclohexane-(4-carboxyphthalato) platinum(II) in patients with refractory germ cell tumors.
Chun H; Bosl GJ; Golbey RB
Cancer Treat Rep; 1985 Apr; 69(4):459-60. PubMed ID: 2986834
[No Abstract] [Full Text] [Related]
15. Nonseminomatous germ cell tumor after chemotherapy with residual mass invading the spine: part 2.
Berglund RK; Lyden SP; Tsai EC; Lieberman I; Klein EA
Eur Urol; 2006 Sep; 50(3):607-8. PubMed ID: 16977689
[No Abstract] [Full Text] [Related]
16. Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group.
Powles T; Shamash J; Berney D; Oliver RT
Br J Cancer; 2003 Sep; 89(6):1140-1; author reply 1141-2. PubMed ID: 12966438
[No Abstract] [Full Text] [Related]
17. Comparative antitumour activity of cisplatin and two new cisplatin-analogues JM8 and JM9 in human testicular carcinoma xenografts.
Harstrick A; Casper J; Schmoll HJ
Int J Androl; 1987 Feb; 10(1):139-45. PubMed ID: 3034790
[TBL] [Abstract][Full Text] [Related]
18. Late relapse of testicular cancer: Recurrence after 24 years and treatment with chemotherapy alone.
Akar E; Tural D; Arslan D; Başsorgun Cİ; Yıldız Ö
J Cancer Res Ther; 2015; 11(3):661. PubMed ID: 26458676
[TBL] [Abstract][Full Text] [Related]
19. Surgical management of early-stage nonseminomatous germ cell tumors of the testis.
Lieskovsky G; Weinberg AC; Skinner DG
Semin Urol; 1984 Nov; 2(4):208-16. PubMed ID: 6095395
[No Abstract] [Full Text] [Related]
20. Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors.
Park S; Lee S; Lee J; Park SH; Park JO; Kang WK; Park YS; Lim HY
Onkologie; 2011; 34(8-9):416-20. PubMed ID: 21934340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
